Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The price of Gilead Sciences, Inc (NASDAQ: GILD) closed at $124.07 in the last session, up 1.90% from day before closing price of $121.76. In other words, the price has increased by $1.90 from its previous closing price. On the day, 4.66 million shares were traded. GILD stock price reached its highest trading level at $124.1 during the session, while it also had its lowest trading level at $121.645.
Ratios:
We take a closer look at GILD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.80. For the most recent quarter (mrq), Quick Ratio is recorded 1.31 and its Current Ratio is at 1.45. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 1.03.
On November 13, 2025, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $140.Scotiabank initiated its Sector Outperform rating on November 13, 2025, with a $140 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 29 ’25 when O’Day Daniel Patrick sold 10,000 shares for $124.83 per share. The transaction valued at 1,248,272 led to the insider holds 566,698 shares of the business.
DANIEL O’DAY bought 10,000 shares of GILD for $1,248,272 on Dec 29 ’25. On Dec 15 ’25, another insider, Dickinson Andrew D, who serves as the Chief Financial Officer of the company, sold 3,000 shares for $122.00 each. As a result, the insider received 366,000 and left with 153,503 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GILD now has a Market Capitalization of 153946914816 and an Enterprise Value of 170298114048. As of this moment, Gilead’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.22, and their Forward P/E ratio for the next fiscal year is 14.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.54. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.30 while its Price-to-Book (P/B) ratio in mrq is 7.15. Its current Enterprise Value per Revenue stands at 5.855 whereas that against EBITDA is 12.047.
Stock Price History:
The Beta on a monthly basis for GILD is 0.37, which has changed by 0.32853246 over the last 52 weeks, in comparison to a change of 0.17287207 over the same period for the S&P500. Over the past 52 weeks, GILD has reached a high of $128.70, while it has fallen to a 52-week low of $89.83. The 50-Day Moving Average of the stock is 0.78%, while the 200-Day Moving Average is calculated to be 8.56%.
Shares Statistics:
According to the various share statistics, GILD traded on average about 6.88M shares per day over the past 3-months and 5676200 shares per day over the past 10 days. A total of 1.24B shares are outstanding, with a floating share count of 1.24B. Insiders hold about 0.21% of the company’s shares, while institutions hold 88.04% stake in the company. Shares short for GILD as of 1767139200 were 23154890 with a Short Ratio of 3.37, compared to 1764288000 on 18479939. Therefore, it implies a Short% of Shares Outstanding of 23154890 and a Short% of Float of 1.87.
Dividends & Splits
The forward annual dividend rate for GILD is 3.16, which was 3.14 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 0.025788438. The stock’s 5-year Average Dividend Yield is 3.79. The current Payout Ratio is 805.23% for GILD, which recently paid a dividend on 2025-12-15 with an ex-dividend date of 2025-12-15. Stock splits for the company last occurred on 2013-01-28 when the company split stock in a 2:1 ratio.
Earnings Estimates
. The current assessment of Gilead Sciences, Inc (GILD) involves the perspectives of 22.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is $2.03, with high estimates of $2.39 and low estimates of $1.73.
Analysts are recommending an EPS of between $8.3 and $7.9 for the fiscal current year, implying an average EPS of $8.15. EPS for the following year is $8.77, with 28.0 analysts recommending between $9.95 and $6.38.
Revenue Estimates
According to 19 analysts,. The current quarter’s revenue is expected to be $7.68B. It ranges from a high estimate of $8.2B to a low estimate of $6.95B. As of. The current estimate, Gilead Sciences, Inc’s year-ago sales were $7.57BFor the next quarter, 19 analysts are estimating revenue of $6.93B. There is a high estimate of $7.25B for the next quarter, whereas the lowest estimate is $6.54B.
A total of 25 analysts have provided revenue estimates for GILD’s current fiscal year. The highest revenue estimate was $29.72B, while the lowest revenue estimate was $28.6B, resulting in an average revenue estimate of $29.21B. In the same quarter a year ago, actual revenue was $28.75BBased on 27 analysts’ estimates, the company’s revenue will be $30.17B in the next fiscal year. The high estimate is $31.25B and the low estimate is $28.86B.
